Adenovirus-vectored T cell vaccine for hepacivirus shows reduced effectiveness against a CD8 T cell escape variant in rats.
There is an urgent need for a vaccine to prevent chronic infection by hepatitis C virus (HCV) and its many genetic variants. The first human vaccine trial, using recombinant viral vectors that stimulate pan-genotypic T cell responses against HCV non-structural proteins, failed to demonstrate efficac...
Saved in:
| Main Authors: | Alex S Hartlage, Piyush Dravid, Christopher M Walker, Amit Kapoor |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-03-01
|
| Series: | PLoS Pathogens |
| Online Access: | https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1009391&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discovery of a Rodent Hepacivirus in the Brazilian Amazon
by: Nelielma G. Oliveira Prestes, et al.
Published: (2025-06-01) -
Can non-lytic CD8+ T cells drive HIV-1 escape?
by: Nafisa-Katrin Seich Al Basatena, et al.
Published: (2013-01-01) -
Reversion and T cell escape mutations compensate the fitness loss of a CD8+ T cell escape mutant in their cognate transmitted/founder virus.
by: Hongshuo Song, et al.
Published: (2014-01-01) -
CD73 is dispensable for the regulation of inflationary CD8+ T-cells after murine cytomegalovirus infection and adenovirus immunisation.
by: Stuart Sims, et al.
Published: (2014-01-01) -
CD8 T cell-mediated depletion of HBV surface-antigen-expressing, bilineal-differentiated liver carcinoma cells generates highly aggressive escape variants
by: Na Qiu, et al.
Published: (2023-12-01)